BlackRock Investment Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $17K | Hold |
1,354
| – | – | ﹤0.01% | 3407 |
|
2016
Q3 | $25K | Hold |
1,354
| – | – | ﹤0.01% | 3301 |
|
2016
Q2 | $14K | Sell |
1,354
-26,235
| -95% | -$271K | ﹤0.01% | 3476 |
|
2016
Q1 | $521K | Buy |
27,589
+352
| +1% | +$6.65K | ﹤0.01% | 2878 |
|
2015
Q4 | $725K | Buy |
27,237
+113
| +0.4% | +$3.01K | ﹤0.01% | 2804 |
|
2015
Q3 | $1.24M | Sell |
27,124
-965
| -3% | -$44K | ﹤0.01% | 2441 |
|
2015
Q2 | $904K | Buy |
28,089
+5,266
| +23% | +$169K | ﹤0.01% | 2840 |
|
2015
Q1 | $726K | Buy |
22,823
+81
| +0.4% | +$2.58K | ﹤0.01% | 2739 |
|
2014
Q4 | $860K | Sell |
22,742
-100
| -0.4% | -$3.78K | ﹤0.01% | 2642 |
|
2014
Q3 | $603K | Buy |
22,842
+634
| +3% | +$16.7K | ﹤0.01% | 2861 |
|
2014
Q2 | $657K | Buy |
22,208
+4,780
| +27% | +$141K | ﹤0.01% | 2875 |
|
2014
Q1 | $645K | Buy |
17,428
+95
| +0.5% | +$3.52K | ﹤0.01% | 2793 |
|
2013
Q4 | $718K | Sell |
17,333
-213
| -1% | -$8.82K | ﹤0.01% | 2725 |
|
2013
Q3 | $930K | Buy |
17,546
+1,105
| +7% | +$58.6K | ﹤0.01% | 2486 |
|
2013
Q2 | $878K | Buy |
+16,441
| New | +$878K | ﹤0.01% | 2465 |
|